BIOMAT Database Logo BIOMAT Database Logo

The hERG potassium channel and drug trapping: insight from docking studies with propafenone derivatives. 2010

Khac-Minh Thai, and Andreas Windisch, and Daniela Stork, and Anna Weinzinger, and Andrea Schiesaro, and Robert H Guy, and Eugen N Timin, and Steffen Hering, and Gerhard F Ecker
Department of Medicinal Chemistry, Emerging Field Pharmacoinformatics, University of Vienna, Althanstrasse 14, 1090 Wien, Austria.

The inner cavity of the hERG potassium ion channel can accommodate large, structurally diverse compounds that can be trapped in the channel by closure of the activation gate. A small set of propafenone derivatives was synthesized, and both use-dependency and recovery from block were tested in order to gain insight into the behavior of these compounds with respect to trapping and non-trapping. Ligand-protein docking into homology models of the closed and open state of the hERG channel provides the first evidence for the molecular basis of drug trapping.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D011405 Propafenone An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity. Apo-Propafenone,Arythmol,Baxarytmon,Cuxafenon,Fenoprain,Jutanorm,Nistaken,Norfenon,Pintoform,Prolecofen,Propafenon AL,Propafenon Hexal,Propafenon Minden,Propafenone Hydrochloride,Propafenone Hydrochloride, (R)-Isomer,Propafenone Hydrochloride, (S)-Isomer,Propafenone, (+-)-Isomer,Propafenone, (R)-Isomer,Propafenone, (S)-Isomer,Propamerck,Rythmol,Rytmo-Puren,Rytmogenat,Rytmonorm,SA-79,Hydrochloride, Propafenone,SA 79,SA79
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000889 Anti-Arrhythmia Agents Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. Anti-Arrhythmia Agent,Anti-Arrhythmia Drug,Anti-Arrhythmic,Antiarrhythmia Agent,Antiarrhythmia Drug,Antiarrhythmic Drug,Antifibrillatory Agent,Antifibrillatory Agents,Cardiac Depressant,Cardiac Depressants,Myocardial Depressant,Myocardial Depressants,Anti-Arrhythmia Drugs,Anti-Arrhythmics,Antiarrhythmia Agents,Antiarrhythmia Drugs,Antiarrhythmic Drugs,Agent, Anti-Arrhythmia,Agent, Antiarrhythmia,Agent, Antifibrillatory,Agents, Anti-Arrhythmia,Agents, Antiarrhythmia,Agents, Antifibrillatory,Anti Arrhythmia Agent,Anti Arrhythmia Agents,Anti Arrhythmia Drug,Anti Arrhythmia Drugs,Anti Arrhythmic,Anti Arrhythmics,Depressant, Cardiac,Depressant, Myocardial,Depressants, Cardiac,Depressants, Myocardial,Drug, Anti-Arrhythmia,Drug, Antiarrhythmia,Drug, Antiarrhythmic,Drugs, Anti-Arrhythmia,Drugs, Antiarrhythmia,Drugs, Antiarrhythmic
D051638 Ether-A-Go-Go Potassium Channels A family of voltage-gated potassium channels that are characterized by long N-terminal and C-terminal intracellular tails. They are named from the Drosophila protein whose mutation causes abnormal leg shaking under ether anesthesia. Their activation kinetics are dependent on extracellular MAGNESIUM and PROTON concentration. ERG Potassium Channels,Eag Potassium Channels,Eag-Related Potassium Channels,Ether-A-Go-Go Related Potassium Channels,Eag Related Potassium Channels,Ether A Go Go Potassium Channels,Ether A Go Go Related Potassium Channels,Potassium Channels, ERG,Potassium Channels, Eag,Potassium Channels, Eag-Related,Potassium Channels, Ether-A-Go-Go

Related Publications

Khac-Minh Thai, and Andreas Windisch, and Daniela Stork, and Anna Weinzinger, and Andrea Schiesaro, and Robert H Guy, and Eugen N Timin, and Steffen Hering, and Gerhard F Ecker
Drug block of the hERG potassium channel: insight from modeling.
August 2007, Proteins,
Khac-Minh Thai, and Andreas Windisch, and Daniela Stork, and Anna Weinzinger, and Andrea Schiesaro, and Robert H Guy, and Eugen N Timin, and Steffen Hering, and Gerhard F Ecker
Blocking effects of the antiarrhythmic drug propafenone on the HERG potassium channel.
April 2001, Naunyn-Schmiedeberg's archives of pharmacology,
Khac-Minh Thai, and Andreas Windisch, and Daniela Stork, and Anna Weinzinger, and Andrea Schiesaro, and Robert H Guy, and Eugen N Timin, and Steffen Hering, and Gerhard F Ecker
Trapping and dissociation of propafenone derivatives in HERG channels.
April 2011, British journal of pharmacology,
Khac-Minh Thai, and Andreas Windisch, and Daniela Stork, and Anna Weinzinger, and Andrea Schiesaro, and Robert H Guy, and Eugen N Timin, and Steffen Hering, and Gerhard F Ecker
Modeling the hERG potassium channel in a phospholipid bilayer: Molecular dynamics and drug docking studies.
April 2008, Journal of computational chemistry,
Khac-Minh Thai, and Andreas Windisch, and Daniela Stork, and Anna Weinzinger, and Andrea Schiesaro, and Robert H Guy, and Eugen N Timin, and Steffen Hering, and Gerhard F Ecker
The low-potency, voltage-dependent HERG blocker propafenone--molecular determinants and drug trapping.
November 2004, Molecular pharmacology,
Khac-Minh Thai, and Andreas Windisch, and Daniela Stork, and Anna Weinzinger, and Andrea Schiesaro, and Robert H Guy, and Eugen N Timin, and Steffen Hering, and Gerhard F Ecker
The hERG potassium channel and hERG screening for drug-induced torsades de pointes.
August 2008, Pharmacology & therapeutics,
Khac-Minh Thai, and Andreas Windisch, and Daniela Stork, and Anna Weinzinger, and Andrea Schiesaro, and Robert H Guy, and Eugen N Timin, and Steffen Hering, and Gerhard F Ecker
Trapping of a methanesulfonanilide by closure of the HERG potassium channel activation gate.
March 2000, The Journal of general physiology,
Khac-Minh Thai, and Andreas Windisch, and Daniela Stork, and Anna Weinzinger, and Andrea Schiesaro, and Robert H Guy, and Eugen N Timin, and Steffen Hering, and Gerhard F Ecker
Astemizole Derivatives as Fluorescent Probes for hERG Potassium Channel Imaging.
March 2016, ACS medicinal chemistry letters,
Khac-Minh Thai, and Andreas Windisch, and Daniela Stork, and Anna Weinzinger, and Andrea Schiesaro, and Robert H Guy, and Eugen N Timin, and Steffen Hering, and Gerhard F Ecker
Interactions between amiodarone and the hERG potassium channel pore determined with mutagenesis and in silico docking.
August 2016, Biochemical pharmacology,
Khac-Minh Thai, and Andreas Windisch, and Daniela Stork, and Anna Weinzinger, and Andrea Schiesaro, and Robert H Guy, and Eugen N Timin, and Steffen Hering, and Gerhard F Ecker
Role of hERG potassium channel assays in drug development.
January 2008, Channels (Austin, Tex.),
Copied contents to your clipboard!